What is the address of KINEPS THERAPY?

The registered office of KINEPS THERAPY is located at Potaerdegatstraat 95 box 1, 1080 Sint-Jans-Molenbeek.

Is KINEPS THERAPY still active?

Yes. According to the CBE (19 September 2026) KINEPS THERAPY is active, legal situation “Normale toestand”, started on 29 March 2022.

Is KINEPS THERAPY registered on Peppol?

No, KINEPS THERAPY is currently not registered on the Peppol network.

What is the enterprise number of KINEPS THERAPY?

The enterprise number of KINEPS THERAPY is BE0783968846.

When was KINEPS THERAPY founded?

KINEPS THERAPY was founded on 29 March 2022.

Who are the directors of KINEPS THERAPY?

According to the 2025 annual accounts, the directors of KINEPS THERAPY are: Taoufik Assbai.

Is KINEPS THERAPY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 March 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did KINEPS THERAPY make in 2025?

KINEPS THERAPY posted a profit after taxes of € 22,032 in financial year 2025.

What is the revenue of KINEPS THERAPY?

As a small company, KINEPS THERAPY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 34,285.

Does KINEPS THERAPY have a website?

Yes, KINEPS THERAPY has a website at kineps-therapy.be.

KINEPS THERAPY (Private Limited) - Sint-Jans-Molenbeek

Dossier KINEPS THERAPY, printed on 19 September 2026 from databakkes.be/en/0783968846/kineps-therapy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

KINEPS THERAPY from Sint-Jans-Molenbeek, company number BE0783968846, closed financial year 2025 with a result of € 22,032 after tax. For that financial year KINEPS THERAPY recorded a gross margin of € 34,285 and equity of € 2,000. Compared with financial year 2024, the result moved from € -5,274 to € 22,032. Profitable, and profit is growing. The buffer shrank hard: equity is 85 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.

What it is worth Shrank hard

€ 2,000

▼ 85% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 22,032

▲ still € 5,274 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 35,265

▲ € 31,092 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 33,411 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 4,702

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 6,788

▲ 236% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 12,729 Gross margin 2022: € 12,729 First fiscal year in the series	€ 13,887 Gross margin 2023: € 13,887 ▲ 9% vs 2022 (€ 12,729) Favourable step	€ 741 Gross margin 2024: € 741 ▼ 95% vs 2023 (€ 13,887) Unfavourable step	€ 34,285 Gross margin 2025: € 34,285 ▲ € 33,544 vs 2024 (€ 741) Favourable step	▲ € 33,544
Profit after taxes	€ 9,820 Profit after taxes 2022: € 9,820 First fiscal year in the series	€ 6,834 Profit after taxes 2023: € 6,834 ▼ 30% vs 2022 (€ 9,820) Unfavourable step	€ -5,274 Profit after taxes 2024: € -5,274 ▼ € 12,108 vs 2023 (€ 6,834) Unfavourable step	€ 22,032 Profit after taxes 2025: € 22,032 ▲ € 27,306 vs 2024 (€ -5,274) Favourable step	▲ € 27,306
Equity	€ 11,820 Equity 2022: € 11,820 First fiscal year in the series	€ 18,653 Equity 2023: € 18,653 ▲ 58% vs 2022 (€ 11,820) Favourable step	€ 13,050 Equity 2024: € 13,050 ▼ 30% vs 2023 (€ 18,653) Unfavourable step	€ 2,000 Equity 2025: € 2,000 ▼ 85% vs 2024 (€ 13,050) Unfavourable step	▼ 85%
Total debts	€ 11,620 Total debts 2022: € 11,620 First fiscal year in the series	€ 7,590 Total debts 2023: € 7,590 ▼ 35% vs 2022 (€ 11,620) Favourable step	€ 5,618 Total debts 2024: € 5,618 ▼ 26% vs 2023 (€ 7,590) Favourable step	€ 43,102 Total debts 2025: € 43,102 ▲ € 37,483 vs 2024 (€ 5,618) Unfavourable step	▲ € 37,483
Cash	€ 23,440 Cash 2022: € 23,440 First fiscal year in the series	€ 6,883 Cash 2023: € 6,883 ▼ 71% vs 2022 (€ 23,440) Unfavourable step	€ 4,173 Cash 2024: € 4,173 ▼ 39% vs 2023 (€ 6,883) Unfavourable step	€ 35,265 Cash 2025: € 35,265 ▲ € 31,092 vs 2024 (€ 4,173) Favourable step	▲ € 31,092
Retained profit	€ 9,820 Retained profit 2022: € 9,820 First fiscal year in the series	€ 16,653 Retained profit 2023: € 16,653 ▲ 70% vs 2022 (€ 9,820) Favourable step	€ 11,050 Retained profit 2024: € 11,050 ▼ 34% vs 2023 (€ 16,653) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 11,050) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 33,411 Dividend 2025: € 33,411 Unchanged (€ 0) Unchanged
Balance sheet total	€ 23,440 Balance sheet total 2022: € 23,440 First fiscal year in the series	€ 26,243 Balance sheet total 2023: € 26,243 ▲ 12% vs 2022 (€ 23,440) Unchanged	€ 18,668 Balance sheet total 2024: € 18,668 ▼ 29% vs 2023 (€ 26,243) Unchanged	€ 45,102 Balance sheet total 2025: € 45,102 ▲ 142% vs 2024 (€ 18,668) Unchanged	▲ 142%

Key figures of KINEPS THERAPY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to KINEPS THERAPY?

What happened at KINEPS THERAPY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 20, 2026 New annual accounts for financial year 2025: profit of € 22,032. Source: NBB ↗
Mar 29, 2022 New establishment in Sint-Jans-Molenbeek. KBO
Mar 29, 2022 Start of the company according to the CBE. KBO

In short

From € 9,820 profit in 2022 to € 22,032 profit in 2025.

Paid € 11,671 in corporate taxes since 2022.

Best year ever: 2025, with € 22,032 profit.

Paid out € 33,411 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at KINEPS THERAPY? We notify you, reason included.

Follow KINEPS THERAPY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Taoufik Assbai

KINEPS THERAPY

Behind KINEPS THERAPY is Taoufik Assbai.

See the full network in the app

Directors

According to the 2025 annual accounts

Taoufik Assbai

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Potaerdegatstraat 95 box 1

1080 Sint-Jans-Molenbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS kineps-therapy.be

Canonical: https://www.kineps-therapy.be

Technologies

BootstrapCloudflare CDNFont AwesomeGoogle AnalyticsGoogle FontsLeafletLightboxOpenStreetMapOwl CarouselPHPjQueryreCAPTCHAunpkg

Hosting & Email

Email provider

Self-hosted

Hosting

OVH, FR

DNS

OVH DNS

Website info

HTTPS Ja

Languages FR

Features

Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number: 0783.968.846
VAT number: BE 0783.968.846
Registered office: Potaerdegatstraat 95 bus 1, 1080 Sint-Jans-Molenbeek
Names & denominations: KINEPS THERAPY
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 March 2022
Peppol: Not registered
Contact: kineps-therapy.be [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗